ABSTRACT
Osteoporosis is a health condition that involves bones and an elevated likelihood of fractures. In the realm of family medicine, the prevention of osteoporosis entails evaluating risks promoting bone health and minimizing the occurrence of fractures. This review explores aspects of care for osteoporosis in family medicine, focusing on early detection and intervention. Family physicians need to be observant of signs like fragility fractures, postural changes, and height loss that indicate osteoporosis. Many different elements, such as one’s age, gender, family medical background and the choices they make in their lifestyle can contribute to the likelihood of developing osteoporosis. These factors also help in devising measures to address the condition effectively. Managing osteoporosis requires an approach led by family physicians that includes lifestyle adjustments, medication interventions tailored to risks, and patient education. Emphasizing weight-bearing exercises, nutrition personalized medications are elements of preventive care. Patient education plays a role in ensuring adherence to prescribed treatments as well as adopting strategies to prevent falls. Tools like FRAX help family physicians assess risks and tailor interventions accordingly. Collaborating with therapists and dietitians further enhances the effectiveness of managing osteoporosis through care. Family doctors go beyond their duties. Take a role in community initiatives that aim to increase awareness offer education and carry out screenings to prevent osteoporosis. Family doctors, as healthcare providers, play a role in minimizing the effects of osteoporosis on bone health and overall well-being. This review provides a summary of measures for osteoporosis, in family medicine emphasizing the significance of early identification, personalized treatment and community involvement.
ABSTRACT
La finalidad del tratamiento de la osteoporosis es la prevención primaria y secundaria de fracturas. Las indicaciones para las intervenciones terapéuticas en la osteoporosis deben derivarse de la determinación del riesgo absoluto de fractura, que tiene en cuenta la evaluación de los factores de riesgo y la densidad ósea. El propósito de este estudio es comentar algunos enfoques terapéuticos empleados en la osteoporosis, destacando el mecanismo de acción del ranelato de estroncio que aumenta la formación de hueso y disminuye la resorción. La causa más común de osteoporosis en las mujeres es la disminución de los niveles de estrógeno durante la menopausia, lo que lleva a un aumento significativo en el recambio de masa ósea y el consiguiente desequilibrio entre la formación y reabsorción ósea con un aumento de la pérdida ósea y el deterioro de la estructura y fuerza óseas. El ranelato de estroncio sigue siendo una opción farmacológica eficaz y viable en la prevención de las fracturas vertebrales y del cuello femoral en mujeres posmenopáusicas y hombres adultos con osteoporosis, en cuanto a indicaciones, contraindicaciones y una cuidadosa evaluación de sus efectos y riesgos. Representa una alternativa a los medicamentos antirresortivos en caso de contraindicación, intolerancia o fracaso(AU)
The purpose of the treatment of osteoporosis is the primary and secondary prevention of fractures. The indications for therapeutic interventions in osteoporosis should be derived from the determination of the absolute risk of fracture, which takes into account the evaluation of risk factors and bone density. To comment on some therapeutic approaches used in osteoporosis, highlighting the mechanism of action of strontium ranelate that increases bone formation and reduces resorption. The most common cause of osteoporosis in women is the decrease in estrogen levels during menopause, which leads to a significant increase in the turnover of bone mass and the consequent imbalance between bone formation and resorption with an increase in bone loss and deterioration of bone structure and strength. Strontium ranelate continues to be an effective and viable pharmacological option in the prevention of vertebral and femoral neck fractures in postmenopausal women and adult men with osteoporosis, in terms of indications, contraindications and a careful evaluation of its effects and risks. It represents an alternative to antiresorptive drugs in case of contraindication, intolerance or failure(AU)
Subject(s)
HumansABSTRACT
PURPOSE: This study was to examine the relationship of knowledge, health beliefs, and prevention behaviors of osteoporotic fracture in outpatients with osteoporosis. METHODS: The subjects were 120 outpatients receiving osteoporosis treatment on K hospital in G city from Dec. 2007 to Feb. 2008. Questionnaires were collected and analyzed using the SPSS/WIN 12.0 program for descriptive statistics, and t-test, ANOVA, and Pearson correlation coefficient. RESULTS: Subjects were treated for fracture about 28 months. The mean score of knowledge, health belief and prevention behaviors in subjects were 17.5 +/- 3.22, 2.8 +/- 0.23 and 2.8 +/- 0.38 respectively. The score of health belief recorded the lowest point. However, the score of knowledge varied with general and disease-related characteristics of subjects. In contrast, the score of prevention behaviors did not showed any significant differences. Fracture prevention behavior in subjects showed rather higher relationship with the health belief system than the knowledge of fracture prevention. CONCLUSION: The present work suggested that education program for prevention behaviors of fracture should be developed to focus on altering the health belief system rather than the knowledge of osteoporotic fracture prevention. Furthermore, individual education program based on living circumstances and daily life habits should be also developed.